Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932.[A226315] Carbamoylcholine was initially used as a treatment for migraines,[A226365] induction of diuresis,[A226370] and other parasympathetic effects. Carbamoylcholine was granted FDA approval on 28 September 1972.[L30245]
Synonyms
Carbacholine
Carbamoylcholine chloride
carbacol
Choline carbamate
Carbamylcholine
Carbamoylcholine
Brand Names
Miostat Ophthalmic Liq 0.01%
Miostat
Isopto Carbachol 1.5%
Carbachol Intraocular Solution 0.01%
Yuvezzi
Isopto Carbachol
Carbachol Tab 2mg
Carbachol
Isopto Carbachol 3%
Carbachol Injection Liq Sc 0.25mg/ml
Carbastat
Indication
Carbamoylcholine is indicated to induce miosis for surgery and to reduce intraocular pressure elevations in the first 24 hours after cataract surgery.[L30245] In combination with [brimonidine], it is used to treat presbyopia in adults.[L55029]
Categories
Alcohols
Amines
Amino Alcohols
Ammonium Compounds
Analgesics
Analgesics, Non-Narcotic
Antiglaucoma Preparations and Miotics
Autonomic Agents
Cardiotonic Agents
Cardiovascular Agents
Central Nervous System Agents
Choline Esters
Cholinergic Agents
Cholinergic Agonists
Cholinergic Receptor Agonist
Compounds used in a research, industrial, or household setting
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682